Arcesium LLC v. Advent Software, Inc.

Background

Arcesium LLC sued Advent Software, Inc. and SS&C Technologies Holdings, Inc. The complaint asserted federal and state antitrust claims, breach-of-contract claims, tortious-interference claims, and an unfair-trade-practices claim under New York law.

Arcesium had entered into a reseller agreement with Advent that allowed it to incorporate Advent’s Geneva portfolio-accounting software into Arcesium’s platform and sell the software to Arcesium’s customers. The agreement expired in January 2020 after the parties did not reach a renewal. Arcesium alleged that the defendants later ended rights that survived the agreement, terminated access connected to Geneva, and used customer agreements that restricted customers from working with Arcesium.

Arcesium alleged that these actions were part of a plan to exclude it from the market for post-trade solutions and harm competition. It identified markets for portfolio-accounting software and post-trade solutions and alleged that the defendants’ conduct involved refusing to deal with Arcesium and imposing exclusive-dealing arrangements on some customers.

Motion and legal standard

The defendants moved to dismiss under Rule 12(b)(6), which permits dismissal when a complaint does not adequately state a legally recognizable claim. They argued, among other things, that Arcesium lacked antitrust standing and had not adequately alleged the relevant markets or anticompetitive conduct.

At the motion-to-dismiss stage, the court had to accept well-pleaded factual allegations as true and draw reasonable inferences in Arcesium’s favor, but it did not have to accept conclusory allegations or legal conclusions presented as facts.

Antitrust standing

The court held that Arcesium failed to plead antitrust standing. Antitrust standing is the legal requirement that a plaintiff show both an injury of the type the antitrust laws are meant to prevent and that the plaintiff is an appropriate party to enforce those laws.

First, the court found that Arcesium had not plausibly alleged an antitrust injury. The court concluded that the defendants’ decision not to renew the reseller agreement was not, as pleaded, an anticompetitive refusal to deal. The defendants had attempted to negotiate a renewal, although Arcesium considered the proposed terms unfavorable, and the complaint did not allege facts bringing the conduct within the narrow exception for terminating a previously profitable cooperative relationship in order to harm competition.

The court also found that Arcesium’s allegations about market-wide harm were speculative and conclusory. Arcesium alleged that prices could rise, product quality could decline, and competitors could lose business, but it did not allege that prices had actually risen, that competitors had actually lost business, or that the quality of products in the market had declined. The court further held that simply alleging that Arcesium’s platform was superior did not adequately show a market-wide decline in quality.

The court determined that Arcesium also had not shown that its alleged injury flowed from anticompetitive conduct. The harm arising from the nonrenewal of the reseller agreement flowed from the defendants’ exercise of a contractual right, according to the court. As to the exclusive-dealing arrangements, the court found that Arcesium had alleged fewer than five lost business opportunities and had not adequately shown that the arrangements blocked access to a significant portion of the relevant market.

Second, the court held that Arcesium had not shown that it was an efficient enforcer of the antitrust laws. The court considered the directness of the injury, whether another group was better positioned to sue, how speculative the damages were, and the possibility of duplicative damages. It found that customers directly affected by the alleged restrictions were better positioned to bring claims, that Arcesium’s damages would require speculation about what third parties might have done, and that there was some risk of overlapping damages claims.

Other claims and disposition

Because the federal antitrust claims failed for lack of antitrust standing, the court did not decide the defendants’ alternative arguments about whether those claims failed on their substantive merits. The court also declined to exercise supplemental jurisdiction, meaning jurisdiction over related state-law claims, after dismissing the only federal claims.

The court granted the defendants’ motion to dismiss on the ground that Arcesium had not established antitrust standing. It dismissed all of Arcesium’s claims, including the state-law claims. The court stated that Arcesium may be able to correct the identified deficiencies and allowed it to move for leave to file an amended complaint, with a marked-up copy, within 30 days. The clerk was directed to close the case.